Skip to search formSkip to main contentSkip to account menu

Multiple Sclerosis, Relapsing-Remitting

Known as: Remitting Relapsing Multiple Sclerosis, Relapsing Remitting Multiple Sclerosis, Multiple Sclerosis, Remitting-Relapsing 
The most common clinical variant of MULTIPLE SCLEROSIS, characterized by recurrent acute exacerbations of neurologic dysfunction followed by partial… 
National Institutes of Health

Related topics

Related topics

10 relations
GlatiramerIn BloodMicrobiologicalMultiple Sclerosis, Acute Relapsing

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2006
Highly Cited
2006
Sequential maintenance treatment with glatiramer acetate after mitoxantrone is safe and can limit exposure to immunosuppression in very active, relapsing remitting multiple sclerosis
Mitoxantrone has been approved by the FDA for worsening relapsing remitting and secondary progressive Multiple Sclerosis. However… 
Highly Cited
2005
Highly Cited
2005
A randomized, multicentre, open-label, parallel-group trial of the tolerability of interferon beta-1a (Rebif®) administered by autoinjection or manual injection in relapsing-remitting multiple…
Injection site reactions (ISRs) are a common side effect of subcutaneous interferon beta therapy, particularly during initiation… 
Highly Cited
2000
Highly Cited
2000
Sex and age at diagnosis are correlated with the HLA-DR2, DQ6 haplotype in multiple sclerosis
Highly Cited
2000
Highly Cited
2000
Short-term prognosis in early relapsing-remitting multiple sclerosis
Objective: To characterize a group of patients with early MS using prognostic factors and to determine whether these prognostic… 
Highly Cited
1998
Highly Cited
1998
Development of Neutralizing Antibodies in Patients with Relapsing-Remitting Multiple Sclerosis Treated with IFN-β1a
ABSTRACT Sixty-eight patients with relapsing-remitting multiple sclerosis (RRMS) were treated with 3 million or 9 million IU of… 
Highly Cited
1996
Highly Cited
1996
Circulating serum levels of IL-1ra in patients with relapsing remitting multiple sclerosis are normal during remission phases but significantly increased either during exacerbations or in response to…
Interleukin (IL)-1 receptor antagonist (IL-1ra) is a naturally occurring inhibitor of IL-1 which binds to IL-1 receptors without… 
Highly Cited
1991
Highly Cited
1991
Hyperprolactinemia in multiple sclerosis
Highly Cited
1987
Highly Cited
1987
Wisconsin Card Sorting Test performance in relapsing-remitting and chronic-progressive multiple sclerosis.
Comparaison des resultats obtenus au «Wisconsin Card Sorting Test» par deux types de patients atteints de sclerose en plaques… 
Highly Cited
1981
Highly Cited
1981
Complement‐fixing antiperipheral nerve myelin antibodies in patients with inflammatory polyneuritis and with polyneuropathy and paraproteinemia
Serum from patients with peripheral neuropathies was tested for antiperipheral nerve myelin antibodies by complement fixation… 
Highly Cited
1933
Highly Cited
1933
RELAPSING FEBRILE NONSUPPURATIVE PANNICULITIS (WEBER)
There have been many articles on the subject of panniculitis in medical literature. Numerous cases have been reported in which… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)